These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 8083562)
1. Systemic absorption and anticholinergic activity of topically applied tropicamide. Vuori ML; Kaila T; Iisalo E; Saari KM J Ocul Pharmacol; 1994; 10(2):431-7. PubMed ID: 8083562 [TBL] [Abstract][Full Text] [Related]
2. Systemic and ocular absorption and antagonist activity of topically applied cyclopentolate in man. Haaga M; Kaila T; Salminen L; Ylitalo P Pharmacol Toxicol; 1998 Jan; 82(1):19-22. PubMed ID: 9527641 [TBL] [Abstract][Full Text] [Related]
3. Comparative study of the effects of 2% ibopamine, 10% phenylephrine, and 1% tropicamide on the anterior segment. Marchini G; Babighian S; Tosi R; Perfetti S; Bonomi L Invest Ophthalmol Vis Sci; 2003 Jan; 44(1):281-9. PubMed ID: 12506086 [TBL] [Abstract][Full Text] [Related]
4. Plasma kinetics and antagonist activity of topical ocular timolol in elderly patients. Vuori ML; Kaila T Graefes Arch Clin Exp Ophthalmol; 1995 Mar; 233(3):131-4. PubMed ID: 7758979 [TBL] [Abstract][Full Text] [Related]
5. Insulin and tropicamide accumulate in the contralateral, untreated eye of rats following ipsilateral topical administration by a mechanism that does not involve systemic uptake. Patsiopoulos G; Lam V; Lake S; Koevary SB Optometry; 2003 Apr; 74(4):226-32. PubMed ID: 12703687 [TBL] [Abstract][Full Text] [Related]
6. Tropicamide 1% mydriatic effect: comparison between spray in closed eyes and eye drops in open eyes. Portes AJ; Barbosa AC; de Mello GL; Lopes MA; Cavalcanti RS J Ocul Pharmacol Ther; 2012 Dec; 28(6):632-5. PubMed ID: 22775152 [TBL] [Abstract][Full Text] [Related]
7. Effects of two concentrations of topical tropicamide on the Schirmer tear test in clinically normal cats. Selk Ghaffari M; Javadzadeh R; Rajaei SM J Feline Med Surg; 2016 Dec; 18(12):965-969. PubMed ID: 26316517 [TBL] [Abstract][Full Text] [Related]
9. Absorption of ocular timolol: drug concentrations and beta-receptor binding activity in the aqueous humour of the treated and contralateral eye. Saari KM; Ali-Melkkilä T; Vuori ML; Kaila T; Iisalo E Acta Ophthalmol (Copenh); 1993 Oct; 71(5):671-6. PubMed ID: 7906472 [TBL] [Abstract][Full Text] [Related]
10. The effects of tropicamide on mydriasis in young rats exhibiting a natural deficit in passive-avoidance responding. Smith RD; Grzelak ME; Belanger B; Morgan CA Life Sci; 1996; 59(9):753-60. PubMed ID: 8761028 [TBL] [Abstract][Full Text] [Related]
11. The mydriatic effect of multiple doses of tropicamide. Siderov J; Nurse S Optom Vis Sci; 2005 Nov; 82(11):955-8. PubMed ID: 16317370 [TBL] [Abstract][Full Text] [Related]
12. Synergism Between Anticholinergic and Oxime Treatments Against Sarin-Induced Ocular Insult in Rats. Gore A; Brandeis R; Egoz I; Turetz J; Nili U; Grauer E; Bloch-Shilderman E Toxicol Sci; 2015 Aug; 146(2):301-10. PubMed ID: 25956921 [TBL] [Abstract][Full Text] [Related]
13. Ophthalmic beta-blockers: determination of plasma and aqueous humor levels by a radioreceptor assay following multiple doses. Phan TM; Nguyen KP; Giacomini JC; Lee DA J Ocul Pharmacol; 1991; 7(3):243-52. PubMed ID: 1686051 [TBL] [Abstract][Full Text] [Related]
15. Changes in pupil size and intraocular pressure after topical application of 0.5% tropicamide to the eyes of dogs sedated with butorphanol. Jugant S; Grillot AE; Lyarzhri F; Régnier A; Douet JY Am J Vet Res; 2019 Jan; 80(1):95-101. PubMed ID: 30605033 [TBL] [Abstract][Full Text] [Related]
16. Comparison of mydriatic efficacy of spray application and drop instillation of tropicamide 1%. Akman A; Aydin P Eye (Lond); 1999 Oct; 13 ( Pt 5)():653-5. PubMed ID: 10696320 [TBL] [Abstract][Full Text] [Related]
17. Concentrations and antagonist activity of topically applied betaxolol in aqueous humour. Vuori ML; Kaila T; Iisalo E; Saari KM Acta Ophthalmol (Copenh); 1993 Oct; 71(5):677-81. PubMed ID: 7906473 [TBL] [Abstract][Full Text] [Related]
18. The concurrent application of ophthalmic drops. Geyer O; Godel V; Lazar M Aust N Z J Ophthalmol; 1985 Feb; 13(1):63-6. PubMed ID: 4015882 [TBL] [Abstract][Full Text] [Related]
19. Effect of commercial dilating agents on laser flare-cell measurements. Chin PK; Cuzzani OE; Gimbel HV; Sun R Can J Ophthalmol; 1996 Dec; 31(7):362-5. PubMed ID: 8971457 [TBL] [Abstract][Full Text] [Related]
20. Phenylephrine 5% added to tropicamide 0.5% eye drops does not influence retinal oxygen saturation values or retinal vessel diameter in glaucoma patients. Vandewalle E; Abegão Pinto L; Olafsdottir OB; Stalmans I Acta Ophthalmol; 2013 Dec; 91(8):733-7. PubMed ID: 22998076 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]